Concepedia

Jianming He

JH

20

Publications

558

Citations

14

H-Index

2013

Active since

Affiliations

Janssen (United States)(Current)

Janssen (Belgium)

Levine Cancer Institute

Janssen Scientific Affairs (United States)

Janssen (Netherlands)

Jianming He is an author at Janssen (United States) specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

2013–2024

20

Publications

20

Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma

Rafaël Fonseca, Saad Z. Usmani, Maneesha Mehra et al. · BMC Cancer · 2020 · 108 citations · Full text

Validation of a Contemporary Five-tiered Gleason Grade Grouping Using Population-based Data

Jianming He, Peter C. Albertsen, Dirk F. Moore et al. · European Urology · 2016 · 63 citations

, , +4

Patient characteristics and outcomes after ruxolitinib discontinuation in patients with myelofibrosis

John Mascarenhas, Maneesha Mehra, Jianming He et al. · Journal of Medical Economics · 2020 · 54 citations · Full text

Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial

Aurore Perrot, Thierry Façon, Torben Plesner et al. · Journal of Clinical Oncology · 2020 · 40 citations · Full text

Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM)

Michael Willis, Christian Asseburg, Jianming He · Journal of Medical Economics · 2013 · 34 citations · Full text

Rows per page

1–5 of 20